Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Tract Infections

Clinical trial condition

Respiratory Tract Infections

Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.

9,607 public trials 648 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Infections trial results

Completed

Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)

NCT00979407

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Caen, France

GSK Investigational Site Paris, France

GSK Investigational Site Paris, France

GSK Investigational Site Poitiers, France

View Trial Details

Completed

Influenza Vaccine Trial in HIV Uninfected Pregnant Women

NCT01306669

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: RMPRU, Chris Hani Baragwanath Hospital Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Nebulized Hypertonic Saline (3%) Versus Nebulized Adrenaline for Treatment of Bronchiolitis

NCT03614273

Conditions: Bronchial Diseases, Bronchiolitis, Bronchitis, +5 more
Locations: Maulana Azad Medical College New Delhi, National Capital Territory of Delhi, India

View Trial Details

Completed

Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis

NCT01011543

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: CHU St Pierre; pulmonology department Brussels, Belgium

View Trial Details

Completed

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

NCT00652743

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Hong Kong

GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Taipei, Taiwan

View Trial Details

Completed

A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children

NCT01218308

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Dhaka, Bangladesh

GSK Investigational Site Santo Domingo, Dominican Republic

GSK Investigational Site Tegucigalpa, Honduras

GSK Investigational Site Beirut, Lebanon

View Trial Details

Completed

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

NCT00993668

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +14 more
Locations: Birmingham, Alabama, United States

Huntsville, Alabama, United States

Tuscaloosa, Alabama, United States

Peoria, Arizona, United States

View all 41 locations

View Trial Details

Completed

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

NCT00985673

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Stockbridge, Georgia, United States

GSK Investigational Site Raleigh, North Carolina, United States

GSK Investigational Site Austin, Texas, United States

GSK Investigational Site Fort Worth, Texas, United States

View Trial Details

Completed

Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly

NCT00772889

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Clearwater, Florida, United States

GSK Investigational Site Coral Gables, Florida, United States

GSK Investigational Site Milford, Massachusetts, United States

GSK Investigational Site Chaska, Minnesota, United States

View all 29 locations

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children

NCT00764790

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Dothan, Alabama, United States

GSK Investigational Site Benton, Arkansas, United States

View all 69 locations

View Trial Details